Site icon Holiday Recipes to Cook

Victor McKusick, “Mendelian Inheritance in Man”, 1966, Group #F.



Here I present: Victor McKusick, Mendelian Inheritance in Man’, 1966, Group #F.


INTRODUCTION.

“Genomic regions”  is the topic of this blog post.  Although anyone can get a DNA company, such as Ancestry, Familytree & 23&Me to give you “chromosomal paints”; the next steps to reading the nucleiceighty-seven  (87) & mitochondria one (1) reading regions” needs to be addressed.

I am going present genomic group #F (shown ABOVE) which is chromosome  #19, and chromosomes #20 (shown BELOW).

Microsoft WORD has a “read-aloud” function.  If you “copy & paste” the traits of genomic Group #F into a Microsoft WORD document; and press the “read-aloud” button you get a lesson.  This lesson is reading-aloud of the Gateway chromosomes (free at Wikipedia); but now you just listen.  Listening to the “read-aloud” over and over, allows you to learn the “nucleic eighty-seven (87) & mitochondria one (1) reading regions”.

Region 19p1 Traits.

Coxsackie virus sensitivity.

Ataxia, cerebellar, Cayman-type.

Cyclic hematopoiesis.

Convulsions, familial febrile.

Fucosyltransferase-6 deficiency.

Guanidinoacetate methyltransferase deficiency. 

Hypocalciuric hypercalcemia, type II.  

Muscular dystrophy.

Leukemia, myeloid/lymphoid or mixed lineage.

Hirschprung disease.

Wegener granulomatosis autoantigen. 

Peutz-Jeghers syndrome.

Bleeding disorder.

Leukemia, acute lymphoblastic.

Persistent Müllerian duct syndrome, type I.

Atherosclerosis, susceptibility to.

Mucolipidosis.

Malaria, cerebral, susceptibility.

Glutaricaciduria, type I.

Sicca syndrome.

Leprechaunism.

Glioblastoma.

Rabson-Mendenhall syndrome.

Thyroid carcinoma, nonmedullary. 

Diabetes mellitus, insulin’ resistant.

Low density lipoprotein receptor.

REGION 19q1 TRAITS.

Ichthyosis.

Hypercholesterolemia, familial.

Leukemia, T-cell acute lymphobloid.

Arteriopathy, cerebral.

Liposarcoma.

Pseudoachondroplasia.

Mycobacterial and salmonella infections, susceptibility to.

Epiphyseal dysplasia, multiple.

Eye color, green/blue.

Severe-combined, immunodeficiency disease.

Hemiplegic migraine, familial.

Hair color, brown.

Episodic ataxia, type 2.

Leigh syndrome.

Ataxia, spinocerebellar and cerebellar.

MHC class II deficiency.

Leukemia, acute myeloid.

Exostoses, multiple, type 3.

Mannosidosis, alpha, types I and II.

Benign familial infantile convulsions.

Alzheimer disease, late onset.

Leukemia/Lymphoma, B-cell.

Glomerulosclerosis, focal segmental.

Spondylocostal dysostosis, autosomal recessive. 

Deafness, autosomal dominant.

Prostate-specific antigen.

Hypercalcemia, familial benign, Oklahoma type, type III.

Spastic paraplegia, autosomal dominant.

Orofacial cleft.

Cystinuria, types II and III. 

Charcot-Leyden crystal protein.

Nephrosis, congenital, Finnish type.

Hemolytic anemia.

Generalized epilepsy with febrile seizures plus.

Hydrops fetalis. 

Ovarian carcinoma.

Malignant hyperthermia susceptibility.

Microcephaly, autosomal recessive.

Central core disease.

Hyperlipoproteinemia, types 1b and III.

Osteodysplasia, polycystic lipomembranous. 

Myocardial infarction susceptibility.

Maple syrup urine disease, type 1a.

Cytochrome P450 (coumarin resistance).

Camurati-Engelmann disease.

Nicotine addiction, protection from.

Myotonic dystrophy.

X-ray repair.

Heart block, progressive familial, type.

Excision repair.

Optic atrophy.

Xeroderma pigmentosum, group D. 

3-methylglutaconiacaciduria, type III.

Trichothiodystropy.

Cystic fibrosis modifier.

DNA ligase I deficiency.

Meconium ileus in cystic fibrosis, susceptibility to.

Polio virus receptor.

Cone dystrophy.

Herpes virus entry mediator B.

Leber congenital amaurosis.

Glutaricaciduria, type IIB.

Retinitis pigmentosa, late-onset dominant.

Colorectal cancer.

Diabetes mellitus, noninsulin-dependent.

Leukemia, T-cell acute lymphoblastic.

Hyperferritinemia cataract syndrome.

Shaw-related subfamily genes.

Hypogonadism, hypergonadotropic.

Melanoma inhibitory activity.

Retinitis pigmentosa, autosomal dominant.

Cardiomyopathy, familial hypertrophic..

Ectodactyl, ectodermal dysplasia, cleft lip/palate.

REGION 20p1 TRAITS.

Creutzfeldt-Jakob disease. CJD

Diabetes insipidus, neurohypophyseal.   CDI

Gerstmann-Straussler disease.   GSD

McKusick-Kaufman syndrome.   MKKS

Insomnia, fatal familial.   FFI

Cerebral amyloid angiopathy.   HCHWA

Pantothenate kinase associated neurodegeneration.  NBIA1

Thrombophilia.   THPH12

Alagille syndrome.   ALGS1

Myocardial infarction, susceptibility.   MCI1

Corneal dystrophy.  FECD4

Huntington-like neurodegenerative disorder.   HDL1

Inhibitor of DNA binding, dominant negative.   ID1

Anemia, congenital dyserythropoietic.  CDAN2

Facial anomalies syndrome.    ICF1

Acromesomelic dysplasia, Hunter-Thompson type.   AMD2C

Gigantism.  GHRH

Brachydactyly, type C.  BDC

Retinoblastoma.    RBBP9

Chondrodysplasia, Grebe type.   AMD2A

REGION 20q1 TRAITS.

Rous sarcoma.  SRC

Hemolytic anemia.   GSSDE

Colon cancer.   CRC

Myeloid tumor suppressor.       MLRL

Galactosialidosis.  GSL

Breast cancer.   CWS7

Severe combined immunodeficiency.  SCID

Maturity Onset Diabetes of the Young, type 1.  MODY1

Hemolytic anemia.   GSSDE

Diabetes mellitus, noninsulin-dependent.  T2D3

Obesity / hyperinsulinism.    OBHP

Graves disease, susceptibility to.  GRD2

Pseudohypoparathyroidism, type 1a.   PHP1A

Epilepsy, nocturnal frontal lobe and benign neonatal, type 1.   ENFL1

McCune-Albright polyostotic fibrous dysplasia.  MAS

Epiphyseal dysplasia, multiple.  EDM3

Somatotrophinoma.  PITA3

Electo-encephalographic variant pattern.   EEGL

Pituitary ACTH secreting adenoma.   PITA3

Pseudohypoparathytroidism, type 1B.  PHP1B

Shah-Waardenburg syndrome.  WS4B


Exit mobile version